{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:15:05Z","timestamp":1788225305151,"version":"build-2803163510"},"reference-count":92,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clinre.2026.102853","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T23:48:40Z","timestamp":1779752920000},"page":"102853","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of metabolic liver disease on colorectal cancer and liver metastases: Pathophysiology and implications for hepatobiliary surgery"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6732-1595","authenticated-orcid":false,"given":"SM","family":"Schmitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BT","family":"Gr\u00fcnwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tasdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Heise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Bednarsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LR","family":"Heij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"Reschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TF","family":"Ulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"UP","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SA","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clinre.2026.102853_bib0001","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.jhep.2023.07.031","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) definition is better than MAFLD criteria for lean patients with NAFLD","volume":"80","author":"De","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2026.102853_bib0002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2026.102853_bib0003","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.clinre.2026.102853_bib0004","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/liv.13299","article-title":"The epidemiology of non-alcoholic fatty liver disease","volume":"37","author":"Bellentani","year":"2017","journal-title":"Liver Int"},{"issue":"5","key":"10.1016\/j.clinre.2026.102853_bib0005","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.32519","article-title":"Risk of cardiovascular disease and loss in life expectancy in NAFLD","volume":"76","author":"Shang","year":"2022","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.clinre.2026.102853_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101108","article-title":"Non-alcoholic fatty liver disease is associated with greater risk of 30-day hospital readmission in the United States (U.S.)","volume":"28","author":"Paik","year":"2023","journal-title":"Ann Hepatol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102853_bib0007","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.clinre.2026.102853_bib0008","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000423","article-title":"Liver histology is associated with long-term clinical outcomes in patients with metabolic dysfunction-associated steatohepatitis","volume":"8","author":"Younossi","year":"2024","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.clinre.2026.102853_bib0009","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/curroncol30010005","article-title":"The evidence surrounding non-alcoholic fatty liver disease in individuals with cancer: a systematic literature review","volume":"30","author":"George","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clinre.2026.102853_bib0010","doi-asserted-by":"crossref","unstructured":"Collaborators GBDCC. Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol 2022;7(7):627\u201347. doi:10.1016\/S2468-1253(22)00044-9 [published Online First: 2022\/04\/11].","DOI":"10.1016\/S2468-1253(22)00044-9"},{"issue":"1097","key":"10.1016\/j.clinre.2026.102853_bib0011","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/postgradmedj-2016-134383","article-title":"Non-alcoholic fatty liver disease and colorectal cancer","volume":"93","author":"Mikolasevic","year":"2017","journal-title":"Postgr Med J"},{"issue":"2","key":"10.1016\/j.clinre.2026.102853_bib0012","doi-asserted-by":"crossref","first-page":"998","DOI":"10.3390\/curroncol31020075","article-title":"Insulin resistance: the increased risk of cancers","volume":"31","author":"Szablewski","year":"2024","journal-title":"Curr Oncol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102853_bib0013","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"issue":"24","key":"10.1016\/j.clinre.2026.102853_bib0014","doi-asserted-by":"crossref","first-page":"5340","DOI":"10.3390\/nu14245340","article-title":"Clearing steatosis prior to liver surgery for colorectal metastasis: a narrative review and case illustration","volume":"14","author":"Peloso","year":"2022","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.clinre.2026.102853_bib0015","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/MEG.0000000000002859","article-title":"Nonalcoholic fatty liver disease and colorectal cancer: a two-sample bidirectional mendelian randomization analysis","volume":"36","author":"Yang","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.clinre.2026.102853_bib0016","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.tem.2024.02.017","article-title":"Unveiling the cancer risk nexus of the steatotic liver","volume":"35","author":"Kim","year":"2024","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.clinre.2026.102853_bib0017","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41574-020-0329-9","article-title":"Insulin-PI3K signalling: an evolutionarily insulated metabolic driver of cancer","volume":"16","author":"Hopkins","year":"2020","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"10.1016\/j.clinre.2026.102853_bib0018","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/nrgastro.2011.23","article-title":"Excess body weight and obesity\u2013the link with gastrointestinal and hepatobiliary cancer","volume":"8","author":"Kant","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2026.102853_bib0019","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semcancer.2025.05.013","article-title":"The intricate role of adipokines in cancer-related signaling and the tumor microenvironment: insights for future research","volume":"113","author":"Kounatidis","year":"2025","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"10.1016\/j.clinre.2026.102853_bib0020","article-title":"An updated review of resistin and colorectal cancer","volume":"16","author":"Rompou","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.clinre.2026.102853_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110785","article-title":"The effect of adiponectin in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and the potential role of polyphenols in the modulation of adiponectin signaling","volume":"131","author":"Shabalala","year":"2020","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"10.1016\/j.clinre.2026.102853_bib0022","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/me.2009-0498","article-title":"Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation","volume":"24","author":"Kim","year":"2010","journal-title":"Mol Endocrinol"},{"issue":"4","key":"10.1016\/j.clinre.2026.102853_bib0023","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/ijms18040866","article-title":"Adiponectin and intelectin-1: important adipokine players in obesity-related colorectal carcinogenesis","volume":"18","author":"Kawashima","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.clinre.2026.102853_bib0024","doi-asserted-by":"crossref","first-page":"519","DOI":"10.21873\/cgp.20154","article-title":"Synergism of adipocytokine profile and ADIPOQ\/TNF-alpha polymorphisms in NAFLD-associated MetS predict colorectal liver metastases outgrowth","volume":"16","author":"Divella","year":"2019","journal-title":"Cancer Genom Proteom"},{"issue":"5","key":"10.1016\/j.clinre.2026.102853_bib0025","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.pharep.2014.05.015","article-title":"Association between chemotherapy and plasma adipokines in patients with colorectal cancer","volume":"66","author":"Slomian","year":"2014","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.clinre.2026.102853_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.770986","article-title":"Endotoxins and non-alcoholic fatty liver disease","volume":"12","author":"Kessoku","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"10.1016\/j.clinre.2026.102853_bib0027","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1172\/JCI28898","article-title":"TLR4 links innate immunity and fatty acid-induced insulin resistance","volume":"116","author":"Shi","year":"2006","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.clinre.2026.102853_bib0028","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.suronc.2016.05.021","article-title":"Obesity and colorectal liver metastases: mechanisms and management","volume":"25","author":"Pathak","year":"2016","journal-title":"Surg Oncol"},{"issue":"4","key":"10.1016\/j.clinre.2026.102853_bib0029","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MAJ.0b013e3181cef1b7","article-title":"Expression and functional research of TLR4 in human colon carcinoma","volume":"339","author":"Tang","year":"2010","journal-title":"Am J Med Sci"},{"issue":"4","key":"10.1016\/j.clinre.2026.102853_bib0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1245\/s10434-009-0325-8","article-title":"Silencing of TLR4 decreases liver tumor burden in a murine model of colorectal metastasis and hepatic steatosis","volume":"16","author":"Earl","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.clinre.2026.102853_bib0031","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41419-021-04076-x","article-title":"Toll-like receptor 4 is a master regulator for colorectal cancer growth under high-fat diet by programming cancer metabolism","volume":"12","author":"Hu","year":"2021","journal-title":"Cell Death Dis"},{"issue":"5","key":"10.1016\/j.clinre.2026.102853_bib0032","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/sj.bjc.6605558","article-title":"High expression of toll-like receptor 4\/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer","volume":"102","author":"Wang","year":"2010","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.clinre.2026.102853_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.mocell.2024.100010","article-title":"Altered lipid metabolism as a predisposing factor for liver metastasis in MASLD","volume":"47","author":"Kim","year":"2024","journal-title":"Mol Cells"},{"issue":"1","key":"10.1016\/j.clinre.2026.102853_bib0034","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2353\/ajpath.2009.080703","article-title":"High fat diet induced hepatic steatosis establishes a permissive microenvironment for colorectal metastases and promotes primary dysplasia in a murine model","volume":"175","author":"VanSaun","year":"2009","journal-title":"Am J Pathol"},{"issue":"7","key":"10.1016\/j.clinre.2026.102853_bib0035","doi-asserted-by":"crossref","first-page":"7134","DOI":"10.3390\/cimb46070425","article-title":"Mechanobiology in metabolic dysfunction-associated steatotic liver disease and obesity","volume":"46","author":"Rudolph","year":"2024","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"10.1016\/j.clinre.2026.102853_bib0036","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/hep.27378","article-title":"Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1\/CXCR4-dependent neutrophil recruitment in mice","volume":"61","author":"Seubert","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.clinre.2026.102853_bib0037","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1053\/j.gastro.2016.07.043","article-title":"Pancreatic premalignant lesions secrete tissue inhibitor of metalloproteinases-1, which activates hepatic stellate cells via CD63 signaling to create a premetastatic niche in the liver","volume":"151","author":"Grunwald","year":"2016","journal-title":"Gastroenterology"},{"issue":"17","key":"10.1016\/j.clinre.2026.102853_bib0038","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136215","article-title":"Hepatic lipids promote liver metastasis","volume":"5","author":"Li","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.clinre.2026.102853_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.metabol.2018.06.004","article-title":"Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis","volume":"87","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.clinre.2026.102853_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1068432","article-title":"Analysis of the correlation between non-alcoholic fatty liver disease and the risk of colorectal neoplasms","volume":"13","author":"Ye","year":"2022","journal-title":"Front Pharmacol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102853_bib0041","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3904\/kjim.2018.022","article-title":"Association between high fatty liver index and development of colorectal cancer: a nationwide cohort study with 21,592,374 Korean","volume":"35","author":"Choi","year":"2020","journal-title":"Korean J Intern Med"},{"issue":"21","key":"10.1016\/j.clinre.2026.102853_bib0042","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000033867","article-title":"Association between nonalcoholic fatty liver disease and colorectal cancer: a population-based study","volume":"102","author":"Wu","year":"2023","journal-title":"Med (Baltim)"},{"key":"10.1016\/j.clinre.2026.102853_bib0043","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s11739-024-03596-6","article-title":"Fasting hyperglycaemia and fatty liver drive colorectal cancer: a retrospective analysis in 1145 patients","volume":"19","author":"Crudele","year":"2024","journal-title":"Intern Emerg Med"},{"issue":"2","key":"10.1016\/j.clinre.2026.102853_bib0044","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/01.sla.0000217629.94941.cf","article-title":"Epidemiology and management of liver metastases from colorectal cancer","volume":"244","author":"Manfredi","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.clinre.2026.102853_bib0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fonc.2020.00251","article-title":"Effect of non-alcoholic fatty liver disease on the risk of synchronous liver metastasis: analysis of 451 consecutive patients of newly diagnosed colorectal cancer","volume":"10","author":"Lv","year":"2020","journal-title":"Front Oncol"},{"issue":"12","key":"10.1016\/j.clinre.2026.102853_bib0046","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1080\/17474124.2019.1697231","article-title":"The progress of non-alcoholic fatty liver disease as the risk of liver metastasis in colorectal cancer","volume":"13","author":"Lv","year":"2019","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.clinre.2026.102853_bib0047","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/iep.12371","article-title":"Fatty change of the liver microenvironment influences the metastatic potential of colorectal cancer","volume":"101","author":"Masaki","year":"2020","journal-title":"Int J Exp Pathol"},{"issue":"1","key":"10.1016\/j.clinre.2026.102853_bib0048","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12885-021-07980-9","article-title":"Baseline liver steatosis has no impact on liver metastases and overall survival in rectal cancer patients","volume":"21","author":"Besutti","year":"2021","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.clinre.2026.102853_bib0049","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3748\/wjg.v21.i3.913","article-title":"Association of nonalcoholic fatty liver disease and liver cancer","volume":"21","author":"Schulz","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clinre.2026.102853_bib0050","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.62347\/JHMS4303","article-title":"Hepatic steatosis predicts metachronous liver metastasis in colorectal cancer patients: a nested case-control study and systematic review","volume":"14","author":"Dai","year":"2024","journal-title":"Am J Cancer Res"},{"issue":"117","key":"10.1016\/j.clinre.2026.102853_bib0051","first-page":"1390","article-title":"Colorectal liver metastases rarely occur in patients with chronic hepatitis virus infection","volume":"59","author":"Wang","year":"2012","journal-title":"Hepatogastroenterology"},{"issue":"6","key":"10.1016\/j.clinre.2026.102853_bib0052","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0002-9610(01)00634-1","article-title":"Rare occurrence of metastatic colorectal cancers in livers with replicative hepatitis B infection","volume":"181","author":"Song","year":"2001","journal-title":"Am J Surg"},{"key":"10.1016\/j.clinre.2026.102853_bib0053","article-title":"A retrospective case-series of influence of chronic hepatitis B on synchronous liver metastasis of colorectal cancer","volume":"13","author":"Zhu","year":"2023","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.clinre.2026.102853_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108618","article-title":"Patients with chronically diseased livers have lower incidence of colorectal liver metastases: a meta-analysis","volume":"9","author":"Cai","year":"2014","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.clinre.2026.102853_bib0055","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.3390\/cancers13092246","article-title":"The effect of diffuse liver diseases on the occurrence of liver metastases in cancer patients: a systematic review and meta-analysis","volume":"13","author":"Monelli","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.clinre.2026.102853_bib0056","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0002-9610(05)80380-0","article-title":"Absence of colorectal cancer metastasis to the cirrhotic liver","volume":"164","author":"Uetsuji","year":"1992","journal-title":"Am J Surg"},{"issue":"1","key":"10.1016\/j.clinre.2026.102853_bib0057","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13000-021-01076-5","article-title":"Metastases can occur in cirrhotic livers with patent portal veins","volume":"16","author":"Mahdi","year":"2021","journal-title":"Diagn Pathol"},{"issue":"2","key":"10.1016\/j.clinre.2026.102853_bib0058","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/jjco\/hyu178","article-title":"Effect of liver cirrhosis on metastasis in colorectal cancer patients: a nationwide population-based cohort study","volume":"45","author":"Chiou","year":"2015","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clinre.2026.102853_bib0059","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/bjs.5719","article-title":"Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases","volume":"94","author":"Zorzi","year":"2007","journal-title":"Br J Surg"},{"issue":"13","key":"10.1016\/j.clinre.2026.102853_bib0060","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1200\/JCO.2005.05.3074","article-title":"Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases","volume":"24","author":"Vauthey","year":"2006","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.clinre.2026.102853_bib0061","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/bjs.10572","article-title":"Systematic review of the influence of chemotherapy-associated liver injury on outcome after partial hepatectomy for colorectal liver metastases","volume":"104","author":"Zhao","year":"2017","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.clinre.2026.102853_bib0062","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.hpb.2017.08.030","article-title":"Impact of chemotherapy-associated liver injury on tumour regression grade and survival in patients with colorectal liver metastases","volume":"20","author":"Zhao","year":"2018","journal-title":"HPB (Oxf)"},{"issue":"5","key":"10.1016\/j.clinre.2026.102853_bib0063","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/SLA.0b013e3182a6183e","article-title":"Liver resection for colorectal metastases after chemotherapy: impact of chemotherapy-related liver injuries, pathological tumor response, and micrometastases on long-term survival","volume":"258","author":"Vigano","year":"2013","journal-title":"Ann Surg"},{"issue":"7","key":"10.1016\/j.clinre.2026.102853_bib0064","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s12094-019-02245-1","article-title":"Splenic volume as a biomarker of hepatic damage after chemotherapy in patients with resected colorectal liver metastases (CRLM)","volume":"22","author":"Saez-Carlin","year":"2020","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"10.1016\/j.clinre.2026.102853_bib0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.21037\/hbsn-24-121","article-title":"Splenic hypertrophy predicts liver-specific complications in patients undergoing major liver resection for colorectal liver metastases, after preoperative chemotherapy","volume":"14","author":"Josephs","year":"2025","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"5","key":"10.1016\/j.clinre.2026.102853_bib0066","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4254\/wjh.v6.i5.306","article-title":"Metabolic syndrome and non-alcoholic fatty liver disease in liver surgery: the new scourges?","volume":"6","author":"Cauchy","year":"2014","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.clinre.2026.102853_bib0067","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.sla.0000225113.88433.cf","article-title":"Steatosis as a risk factor in liver surgery","volume":"245","author":"Vetelainen","year":"2007","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.clinre.2026.102853_bib0068","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s11605-012-2044-x","article-title":"Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk","volume":"16","author":"Zarzavadjian Le Bian","year":"2012","journal-title":"J Gastrointest Surg"},{"issue":"6","key":"10.1016\/j.clinre.2026.102853_bib0069","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/bjs.9057","article-title":"Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases","volume":"100","author":"Hamady","year":"2013","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.clinre.2026.102853_bib0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/jcm10010098","article-title":"Does hepatic steatosis influence the detection rate of metastases in the hepatobiliary phase of Gadoxetic acid-enhanced MRI?","volume":"10","author":"Steffen","year":"2020","journal-title":"J Clin Med"},{"issue":"12","key":"10.1016\/j.clinre.2026.102853_bib0071","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1007\/s00268-021-06230-0","article-title":"Hepatic steatosis is associated with an increased risk of postoperative infections and perioperative transfusion requirements in patients undergoing hepatectomy","volume":"45","author":"Villagomez","year":"2021","journal-title":"World J Surg"},{"issue":"11","key":"10.1016\/j.clinre.2026.102853_bib0072","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/bjs.5820","article-title":"Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis","volume":"94","author":"Gomez","year":"2007","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.clinre.2026.102853_bib0073","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.surg.2014.02.020","article-title":"Hepatic steatosis is associated with surgical-site infection after hepatic and colorectal surgery","volume":"156","author":"Kurmann","year":"2014","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.clinre.2026.102853_bib0074","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/01.sla.0000251747.80025.b7","article-title":"Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study","volume":"245","author":"McCormack","year":"2007","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.clinre.2026.102853_bib0075","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1002\/hep.25935","article-title":"Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study","volume":"56","author":"Reddy","year":"2012","journal-title":"Hepatology"},{"issue":"3 Pt B","key":"10.1016\/j.clinre.2026.102853_bib0076","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ejso.2020.10.016","article-title":"Case-mix adjustment to compare nationwide hospital performances after resection of colorectal liver metastases","volume":"47","author":"Elfrink","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.clinre.2026.102853_bib0077","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/bjs.7194","article-title":"Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection","volume":"97","author":"de Meijer","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/j.clinre.2026.102853_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105482","article-title":"Microbiome and metabolomics reveal the effect of gut microbiota on liver regeneration of fatty liver disease","volume":"111","author":"Hu","year":"2025","journal-title":"EBioMedicine"},{"issue":"6","key":"10.1016\/j.clinre.2026.102853_bib0079","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/hpb.12007","article-title":"The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without preoperative chemotherapy","volume":"15","author":"Parkin","year":"2013","journal-title":"HPB (Oxf)"},{"issue":"11","key":"10.1016\/j.clinre.2026.102853_bib0080","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ejso.2014.07.040","article-title":"Equivalent survival in patients with and without steatosis undergoing resection for colorectal liver metastases following pre-operative chemotherapy","volume":"40","author":"Parkin","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.clinre.2026.102853_bib0081","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000510661","article-title":"Chemotherapy and hepatic steatosis: impact on postoperative morbidity and survival after liver resection for colorectal liver metastases","volume":"37","author":"Mahlmann","year":"2021","journal-title":"Visc Med"},{"key":"10.1016\/j.clinre.2026.102853_bib0082","doi-asserted-by":"crossref","first-page":"8315","DOI":"10.2147\/CMAR.S210185","article-title":"Predictive and prognostic value of hepatic steatosis In conversion therapy for colorectal liver-limited metastases: a propensity score matching analysis","volume":"Volume 11","author":"Jian","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.clinre.2026.102853_bib0083","article-title":"The impact of hepatic steatosis on outcomes of colorectal cancer patients with liver metastases: a systematic review and meta-analysis","volume":"9","author":"Yang","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"5","key":"10.1016\/j.clinre.2026.102853_bib0084","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00423-022-02482-z","article-title":"Fat signal fraction assessed with MRI predicts hepatic recurrence following hepatic resection for colorectal liver metastases","volume":"407","author":"Sakai","year":"2022","journal-title":"Langenbeck's Arch Surg"},{"issue":"3","key":"10.1016\/j.clinre.2026.102853_bib0085","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3747\/co.24.3133","article-title":"Effect of non-alcoholic liver disease on recurrence rate and liver regeneration after liver resection for colorectal liver metastases","volume":"24","author":"Molla","year":"2017","journal-title":"Curr Oncol"},{"issue":"8","key":"10.1016\/j.clinre.2026.102853_bib0086","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00384-013-1656-2","article-title":"Hepatic steatosis is associated with lower incidence of liver metastasis from colorectal cancer","volume":"28","author":"Murono","year":"2013","journal-title":"Int J Colorectal Dis"},{"issue":"1","key":"10.1016\/j.clinre.2026.102853_bib0087","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/bjc.2016.155","article-title":"The impact of hepatic fibrosis on the incidence of liver metastasis from colorectal cancer","volume":"115","author":"Kondo","year":"2016","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.clinre.2026.102853_bib0088","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s12029-024-01042-6","article-title":"Non-alcoholic fatty liver disease may Be a risk factor for liver metastasis after radical surgery for colorectal cancer: a retrospective study","volume":"55","author":"Miyata","year":"2024","journal-title":"J Gastrointest Cancer"},{"issue":"3","key":"10.1016\/j.clinre.2026.102853_bib0089","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1097\/JS9.0000000000002252","article-title":"Non-enhanced abbreviated MRI as a periodic surveillance protocol for colorectal liver metastases compared with contrast-enhanced CT: a prospective observational study","volume":"111","author":"Liu","year":"2025","journal-title":"Int J Surg"},{"issue":"4","key":"10.1016\/j.clinre.2026.102853_bib0090","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/jcsm.12723","article-title":"Ectopic fat in liver and skeletal muscle is associated with shorter overall survival in patients with colorectal liver metastases","volume":"12","author":"van Dijk","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"2","key":"10.1016\/j.clinre.2026.102853_bib0091","first-page":"165","article-title":"Non-alcoholic fatty liver disease and colorectal cancer survival","volume":"30","author":"Wu","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"1","key":"10.1016\/j.clinre.2026.102853_bib0092","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1158\/1940-6207.CAPR-22-0332","article-title":"Treatment strategies and mechanisms associated with the prevention of NASH-associated HCC by a toll-like receptor 4 inhibitor","volume":"16","author":"Kwan","year":"2023","journal-title":"Cancer Prev Res (Phila)"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:45:51Z","timestamp":1788223551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740126000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":92,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2210740126000999"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102853","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of metabolic liver disease on colorectal cancer and liver metastases: Pathophysiology and implications for hepatobiliary surgery","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102853","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102853"}}